Renal Denervation Market Size, Trend, Analysis 2032
Renal Denervation Market Highlights
The Renal Denervation Market Size was valued at USD
0.8 Billion in 2023 and is projected to grow from USD 1.11 Billion in 2023 to
USD 15.09 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of
38.60% during the forecast period (2023 - 2032).
The global renal denervation market trends is expected to be driven mainly by the rising prevalence of
hypertension around the world. Hypertension has been one of the main
beneficiaries of the modern lifestyles and dietary patterns and has grown in
prevalence steadily over the last decade and more. This trend is likely to be
followed over the coming years as more countries experience the negative
effects of rapid urbanization and wide-scale industrialization on the health of
the population. Hypertension is likely to be one of the diseases on the rise in
developing countries that are pursuing large-scale urbanization and
industrialization, leading to favourable growth prospects for the renal
denervation market in emerging economies such as China and India.
Segmentation:
The global renal denervation market insights is segmented based on product, technology, and end
use.
By product, the renal denervation market is
segmented into Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and others.
Simplicity holds the largest market share in the renal denervation market at
present and is likely to remain a leading contributor over the forecast period.
However, Paradise is likely to be the fastest growing product segment in the
renal denervation market over the forecast period.
Based on technology, the global renal denervation
market is divided into radiofrequency, ultrasound, micro-infusion, and others.
Radiofrequency is likely to be the fastest growing segment over the forecast
period, eclipsing ultrasound, the largest market segment at present, in terms
of growth rate.
By end user, the renal denervation market is
segmented into hospitals, clinics, ambulatory surgical centres, and others.
Hospitals are the largest segment in the global renal denervation market, while
ambulatory surgical centres are expected to exhibit the fastest growth over the
forecast period.
Regional Analysis:
By region, the global renal denervation market is segmented into North America, Europe,
Asia Pacific (APAC), and Rest of the world.
Europe is likely to dominate the global renal
denervation market over the forecast period due to the strong research
infrastructure in the region and the increasing development of progressively
more advanced renal denervation devices. The increasing prevalence of
drug-resistant hypertension in Europe is further likely to drive research in
the renal denervation market, ensuring Europe’s dominance in the renal
denervation market over the forecast period.
Asia Pacific is also likely to be a major regional market for renal
denervation over the forecast period due to the growing prevalence of
hypertension and the steady improvement in healthcare infrastructure. This is
likely to ensure widespread availability of renal denervation devices as well
as increasing research into product development to produce more advanced renal
denervation devices over the forecast period.
Renal
Denervation Market Players
The global renal denervation market players
include Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical,
Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment